We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Series E raises whopping $89mm for ConforMIS; expands round to $167.7mm
05 Aug 2013
Executive Summary
ConforMIS Inc. (orthopedic implants) pulled in $89mm in its Series E financing round to private equity funds from the US, Europe, Asia, and the Middle East. Lead investors were AGC Equity Partners, Axel Johnson, and government investment funds from Asia and the UAE. The money will support sales and marketing activities and scaled-up manufacturing for its knee replacement systems. The company stands to receive additional milestone-based funds.
Deal Industry
Medical Devices
Medical Devices
Implantable Devices
Surgical Equipment & Devices
Minimally or Less Invasive
Deal Status
Final
Deal Type
Financing
Venture Financing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?